HCPCS Code G0105: A Guide to Colorectal Cancer Screening for High-Risk Patients

The world of medical coding includes not only drugs and devices but also preventive services that are essential for maintaining public health. HCPCS code G0105 is a perfect example. It is a code used to bill for a specific type of colorectal cancer screening, one of the most effective tools in modern medicine for preventing a deadly disease. Understanding this code is important for gastroenterologists, primary care physicians, billing teams, and patients alike. This guide provides a comprehensive, clear, and practical overview of HCPCS code G0105, its clinical significance, and the specific rules governing its use.

What Exactly is HCPCS Code G0105?

In simple terms, HCPCS code G0105 is the billing code for a colorectal cancer screening performed via colonoscopy on an individual who is considered at high risk for developing colorectal cancer. It is a “G code,” which is a category of HCPCS codes used for temporary procedures and professional services, often related to Medicare’s preventive care initiatives.

This code is not for a diagnostic colonoscopy. A diagnostic colonoscopy is performed when a patient has signs or symptoms of a problem, such as blood in the stool, chronic diarrhea, or abdominal pain. A screening colonoscopy is performed on a patient who has no symptoms at all. The goal is to find and remove precancerous polyps (adenomas) before they can turn into cancer.

The code G0105 is specifically for the screening service. It is used when the procedure is initiated as a preventive service for a patient who meets the “high risk” criteria defined by Medicare. This designation is critical because it affects how the patient’s financial responsibility is calculated under Medicare rules.

Key Details at a Glance

Here is a quick reference table summarizing the essential facts about this HCPCS code.

---

The Procedure Behind the Code: Screening Colonoscopy

To fully understand this code, one must understand the procedure it represents and why it is such a powerful tool in the fight against cancer.

What is a Colonoscopy?

A colonoscopy is a medical procedure that allows a physician to directly visualize the entire lining of the large intestine (colon) and rectum. The physician uses a long, flexible tube called a colonoscope, which has a tiny camera and light at its tip. The scope is gently inserted through the rectum and advanced through the colon.

During the procedure, the physician can:

• Visualize the colon lining to look for abnormalities.

• Remove polyps: Small growths on the colon lining. While most are benign, some (adenomas) can develop into cancer over time. Removing them during a colonoscopy prevents cancer from developing.

• Take biopsies: Small tissue samples can be taken for laboratory analysis if needed.

The procedure is typically performed under sedation to ensure patient comfort.

Why is Screening Important?

Colorectal cancer is the third most common cancer diagnosed in both men and women. It is also one of the most preventable cancers. This is because it usually develops slowly over many years, starting as a small polyp. If a screening colonoscopy finds and removes these polyps, the risk of developing colorectal cancer is dramatically reduced. The procedure is both diagnostic and therapeutic.

What Makes a Patient “High Risk”?

The code G0105 is specifically for patients who are at high risk for colorectal cancer. According to Medicare guidelines, an individual is considered at high risk if they have one or more of the following:

1. A personal history of adenomatous polyps: A past colonoscopy found and removed precancerous polyps.

2. A personal history of colorectal cancer: The patient has been previously treated for colorectal cancer.

3. A family history of colorectal cancer: A first-degree relative (parent, sibling, or child) has had colorectal cancer or an adenomatous polyp.

4. A personal history of Inflammatory Bowel Disease (IBD): A diagnosis of Crohn’s disease or ulcerative colitis, which increases the risk of colon cancer.

5. A family history of a hereditary colorectal cancer syndrome: Such as Familial Adenomatous Polyposis (FAP) or Hereditary Nonpolyposis Colorectal Cancer (HNPCC or Lynch Syndrome).

Patients who do not meet these criteria are considered “average risk.” Their screening colonoscopies are billed with a different code (G0121) or, more commonly, with standard CPT codes.

---

Billing and Coding: Navigating the Rules for G0105

Billing for a screening colonoscopy can be complex because the nature of the procedure can change from “screening” to “diagnostic” or “therapeutic” during the procedure itself. This has significant implications for coding and patient cost-sharing.

The Billing Unit and Companion Codes

G0105 is for the professional service of performing the screening colonoscopy on a high-risk patient. It is billed by the physician. The facility where the procedure is performed (like an ASC or hospital) will bill separately for the use of their resources, often using the same or a corresponding code.

It is helpful to see how G0105 fits into the landscape of colorectal cancer screening codes.

The Challenge: What Happens When a Polyp is Found?

This is the most important billing nuance for screening colonoscopies. A procedure may begin as a “screening” (no symptoms), but if the physician finds and removes a polyp, the nature of the service changes.

• Medicare Rule: Medicare has a specific rule for this situation. When a screening colonoscopy (like G0105) results in a therapeutic intervention (like a polypectomy), the physician should still bill the screening code (G0105) as the primary code. The therapeutic service, like the removal of a polyp, is billed with a standard CPT code (e.g., 45385 for a polypectomy) with a -PT modifier (Colorectal cancer screening test; converted to diagnostic test or other procedure). This modifier tells the payer that the procedure started as a screening.

• Patient Cost-Sharing: The crucial consequence of this rule is that the patient’s cost-sharing (co-insurance and deductible) is waived for the screening service. Even if a polyp is found and removed, the entire procedure is treated as a preventive service for billing purposes. This is a significant patient benefit.

Important Note for Commercial Payers: While Medicare has this clear rule, commercial insurance plans may have different policies. Some follow Medicare’s lead, while others may process the claim differently, potentially applying cost-sharing when a polyp is removed. It is always best practice to verify the patient’s benefits and the payer’s policy before the procedure.

Documentation Requirements

To correctly bill G0105, the medical record must clearly document the patient’s high-risk status. This documentation should be part of the patient’s history and the physician’s order for the procedure.

Key elements to document include:

• The specific reason the patient is considered high risk. For example, “personal history of adenomatous polyps” or “first-degree relative with colorectal cancer.”

• The absence of symptoms. The record should indicate that the patient is asymptomatic and the procedure is for screening purposes.

• The findings and any procedures performed. The operative report must detail what was found and what was done (e.g., “no abnormalities found” or “two polyps removed with snare technique”).

---

Understanding the Cost and Reimbursement

Under the Affordable Care Act (ACA), preventive services like colorectal cancer screening are highly valued and protected.

A Financial Perspective for Patients

• No Out-of-Pocket Costs for the Screening: For Medicare beneficiaries, the Part B deductible and co-insurance are waived for the screening colonoscopy itself when G0105 is billed. This is a key provision of the ACA.

• Polyp Removal is Covered: As discussed, if a polyp is found and removed during the screening, the patient still does not pay a co-insurance or deductible for the screening portion of the service.

• Bowel Preparation: The cost of the bowel preparation solution (the liquid the patient drinks to clean the colon) is typically a pharmacy cost and may be covered under the patient’s Part D plan or require an out-of-pocket payment.

A Financial Perspective for Providers

• Reimbursement: The Medicare Physician Fee Schedule determines the payment rate for G0105. The reimbursement is intended to cover the professional work, practice expense, and malpractice cost of the procedure.

• Coding Accuracy is Key: Billing G0105 incorrectly, or for a patient who does not meet the high-risk criteria, can lead to claim denials or audits. Providers must ensure the patient’s risk status is properly documented.

---

Medicare Coverage for G0105

Medicare has been a leader in promoting colorectal cancer screening.

Medicare Part B (Medical Benefit)

G0105 is billed under Medicare Part B.

• Coverage: Covered for eligible Medicare beneficiaries who meet the definition of “high risk.” The frequency of coverage depends on the specific risk factor. For example, a patient with a history of polyps may be eligible for a screening every 2-5 years, while a patient with a family history may be eligible every 10 years.

• Patient Cost: No deductible or co-insurance is applied for the screening service.

The Welcome to Medicare and Annual Wellness Visits

Colorectal cancer screening is a key component of Medicare’s “Welcome to Medicare” preventive visit and subsequent “Annual Wellness Visits.” During these visits, the physician is expected to discuss the importance of screening and help the patient schedule the appropriate test.

---

Clinical Safety and Patient Experience

A colonoscopy is a very safe and common procedure, but it is not without risks.

Common Preparations and Discomfort

• Bowel Preparation: The most challenging part for many patients is the bowel prep. This involves drinking a large volume of a special liquid the day before the procedure to completely empty the colon. This is essential for a clear view.

• Sedation: Most patients receive “twilight” sedation, which means they are relaxed and sleepy but not fully unconscious. They typically have little to no memory of the procedure.

Potential Risks

While rare, complications can occur. These include:

• Bleeding: This can occur if a polyp is removed. It is usually minor and stops on its own.

• Perforation: A small tear in the wall of the colon. This is a serious complication but is very rare (occurring in less than 1 in 1,000 procedures).

Important Note: The benefits of colorectal cancer screening far outweigh the risks. Finding and removing a precancerous polyp can prevent a future diagnosis of cancer.

---

Frequently Asked Questions (FAQ)

1. What is the difference between G0105 and G0121?
G0105 is for a screening colonoscopy on a patient who is at high risk for colorectal cancer. G0121 is for a screening colonoscopy on a patient who is at average risk.

2. What makes me “high risk” for colorectal cancer?
Factors include a personal history of polyps or colorectal cancer, a family history (first-degree relative), a personal history of inflammatory bowel disease (Crohn’s or ulcerative colitis), or a family history of a genetic syndrome.

3. Will I have to pay a deductible or co-insurance for this test?
For Medicare patients, the answer is no. The deductible and co-insurance are waived for the screening colonoscopy service itself.

4. What happens if my doctor finds a polyp during my screening?
The polyp will typically be removed during the same procedure. Under Medicare rules, the procedure is still billed as a screening, and you will not be charged a co-insurance or deductible. The removal is a covered part of the preventive service.

5. Is this code used for a diagnostic colonoscopy?
No. A diagnostic colonoscopy is performed when a patient has symptoms. It is billed with a different set of CPT codes, and normal cost-sharing rules apply.

6. How often does Medicare cover this screening?
The frequency depends on the specific risk factor. Generally, high-risk patients may be covered every 2 years or every 5-10 years, depending on their history. Physicians must document medical necessity for the frequency.

---

Additional Resources

• American Cancer Society (ACS): Provides detailed information on colorectal cancer screening guidelines. Visit cancer.org.

• Centers for Medicare & Medicaid Services (CMS): The official source for Medicare coverage of preventive services. Visit medicare.gov.

Conclusion

HCPCS code G0105 is the billing code for a screening colonoscopy performed on a patient at high risk for colorectal cancer. It is a powerful preventive service that Medicare supports by waiving patient cost-sharing. The key to successful billing is correctly identifying the patient’s high-risk status and documenting it thoroughly. Understanding the rules for when a polyp is found, and using the -PT modifier correctly, is essential for compliant billing and protecting patients from unexpected costs.